New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
07:01 EDTMYGNMyriad Genetics outlook still positive, says Cantor
After a judge denied Myriad's request for a preliminary injunction against a competitor and Myriad's stock decline more than 8% yesterday, Cantor says it expected the motion to be denied. The firm continues to believe that Myriad's position in the hereditary cancer testing market is strong, and it reiterates a $42 price target and Buy rating on the shares.
News For MYGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 25, 2015
07:41 EDTMYGNMyriad Genetics upgraded on positive risk/reward at Wells Fargo
Subscribe for More Information
06:22 EDTMYGNMyriad Genetics upgraded to Outperform from Market Perform at Wells Fargo
Subscribe for More Information
August 14, 2015
10:19 EDTMYGNMyriad Genetics management to meet with Barclays
Meetings to be held in Houston on August 19 and in Houston/Dallas on August 20 hosted by Barclays.
August 13, 2015
17:17 EDTMYGNOn The Fly: Top stock stories for Thursday
Subscribe for More Information
07:15 EDTMYGNMyriad Genetics receives favorable medicare final coverage decision for Polaris
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use